| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |